Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine

BACKGROUND: Sustained pain freedom is an important attribute of acute migraine therapies for patients and physicians. Here we report efficacy of the centrally penetrant, highly selective, 5-HT(1F) agonist lasmiditan on sustained pain freedom and other outcomes at 24 and 48 hours post-dose. STUDY DES...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cephalalgia
Glavni autori: Doty, Erin Gautier, Krege, John H, Jin, Leah, Raskin, Joel, Halker Singh, Rashmi B, Kalidas, Kavita
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6791026/
https://ncbi.nlm.nih.gov/pubmed/31266353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0333102419859313
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items